Status:
COMPLETED
Pediatric Induction Therapy in Kidney Transplantation
Lead Sponsor:
Gang Chen
Collaborating Sponsors:
Zhejiang University
First Affiliated Hospital, Sun Yat-Sen University
Conditions:
Kidney Transplant Rejection
Pediatric Kidney Disease
Eligibility:
All Genders
1-18 years
Brief Summary
The goal of this observational study is to compare the efficacy of two most commonly used induction therapy for the prevention of acute rejection (AR) after renal transplantation in children. The main...
Eligibility Criteria
Inclusion
- Receiving the kidney graft from a deceased donor
- Basiliximab or rATG induction therapy was used in perioperative period
Exclusion
- Recipients with pre-transplant calculated panel reactive antibodies (cPRA) \>10%
- Recipients of combined liver, pancreas or heart transplantation
- No induction or other induction therapy was used in perioperative period
- Recieving the kidney graft from a living donor
Key Trial Info
Start Date :
March 3 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
958 Patients enrolled
Trial Details
Trial ID
NCT06087003
Start Date
March 3 2013
End Date
September 30 2023
Last Update
October 17 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Sun Yat-sen University.
Guangzhou, Guangdong, China
2
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
3
The First Affiliated Hospital of Zhejiang University
Hangzhou, China
4
Changhai Hospital affiliated to Naval Military Medical University
Shanghai, China